Medical Cannabis Related News
First CBD oil to be approved by the European Medicines Agency
A GW Pharmaceuticals Cannabidiol oral solution, EPIDYOLEX®, is the first plant-derived cannabis-based medicine to be approved by the European Medicines Agency (EMA).
EPIDYOLEX® cannabidiol oral...
Altitude Investment Management invests $5.5 Million in KannaSwiss
Altitude Investment Management announced today a $5.5 (~€5m) million investment in Switzerland-based KannaSwiss as its first European investment.
Earlier this year, Altitude Investment Management plc (AIM plc),...
CannaBiz Innovation Hub 2019: innovation and scale with cannabis
Leading organisations in the cannabis industry will be discussing cannabis products, the supply chain, quality control, marketing, distribution and more at Cannabis Innovation Hub...
Cannabis and mental health: more grey than black and white
Concerns have been raised about the lack of knowledge of the benefits and harms regarding cannabis and mental health
In the UK there is strong...
UK CBD Quality Charter launched by Centre for Medicinal Cannabis
A new Quality Charter has been put forward in the UK to encourage legal compliance within the UK’s medical cannabis industry.
The Centre for Medicinal...
Is global medical cannabis a regulatory compliance business?
For medical and recreational cannabis production, Cannabis OneFive, Inc.’s (C15) solutions fit like a bullseye into a realm of regulatory compliance. Why? Let’s find...
Calls for regulation of medical cannabis devices following health crisis
Industry bodies call for better regulation of medical cannabis devices following the vapourisation health crisis in America.
In a letter to the heads of the US Food...
Research unclear on link between cannabis and psychosis
A number of studies have been looking at the link between cannabis and psychosis, however, much more needs to be done to fully understand...
Society of Cannabis Clinicians announces its official journal
The Society of Cannabis Clinicians (SCC) has announced the new, peer-reviewed Cannabis and Cannabinoid Research journal as its official journal.
The Society of Cannabis Clinicians...
Essential micronutrient can protect foetus from cannabis effects
Critical new research has discovered that an essential micronutrient can help to protect unborn babies from damaging cannabis effects in the womb.
Many women who...
Presenting GCI Europe: the exclusive medical cannabis event
Global Cannabis Intelligence presents its exclusive medical cannabis event – GCI Europe – where global leaders shape the future of European cannabis strategies.
As the...
Research shows cannabis users weigh less than those that do not use it
Despite cannabis increasing appetite, new research shows that cannabis users weigh less than those who do not use it.
The findings from Michigan State University and...
CanaQuest Medical Corp files patent for THC formulation
CanaQuest Medical Corp has filed an International Cannabis/Botanical Patent which stems from its sponsored research program at Western University in London, Ontario, Canada.
The use...
Study shows cannabis flower with high THC levels is effective for pain relief
Researchers have revealed strong evidence that cannabis flower with high levels of THC can significantly reduce pain.
The study, conducted by the The University of...
Canadian federal government pardons previous cannabis convictions
After a month of accepting pardon applications the Canadian federal government has approved 44 out of the 71 applicants of their cannabis convictions.
Canada was the...
UK company set to be largest cannabis company on London stock market
A UK company is planning to list a £100m float on the stock market – poising it be the biggest cannabis company on the...
Lower blood lipids: can you eat a cheeseburger and have a strong heart?
A breakthrough in the battle to, lower blood lipids, reduce cholesterol and Triglycerides comes with weight loss as a bonus.
CannaLean had developed CLC, a...
IASO CORP: developing solutions and investing in cannabis
Iaso is a science company that promotes wellness and remedies through synergistic collaborations and investing in cannabis with key players in the industry.
To understand...
Imperial College London expands its cannabis research programme
Imperial College London and research partner EMMAC will be expanding a cannabis research programme that aims to evaluate the ‘entourage effect’ of cannabinoids for...
Are steroids truly a necessary evil? – a groundbreaking CBD-based alternative
For over 100 chronic inflammatory and autoimmune diseases, steroids remain the first-line treatment – could STERO Biotechs bring the next CBD-based alternative?
Following one of...